Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System
https://seekingalpha.com/news/4427702-zimmer-biomet-wins-ce-mark-ribfix-advantage?source=feed_sector_healthcare
Apr 01, 2025 -
0
Orthofix gets FDA clearance and CE Mark for its limb preservation solution
https://seekingalpha.com/news/4422187-orthofix-gets-fda-clearance-and-ce-mark-for-its-limb-preservation-solution?source=feed_sector_healthcare
Mar 19, 2025 -
0
CES Energy Solutions Corp. (CESDF) Q4 2024 Earnings Call Transcript
https://seekingalpha.com/article/4765783-ces-energy-solutions-corp-cesdf-q4-2024-earnings-call-transcript?source=feed_sector_transcripts
Mar 07, 2025 -
0
Cerus receives CE Mark for INTERCEPT Illumination Device
https://seekingalpha.com/news/4417630-cerus-receives-ce-mark-for-intercept-illumination-device?source=feed_sector_healthcare
Mar 05, 2025 -
0
Stock Market Sleeps On Stereotaxis MAGiC CE Mark
https://seekingalpha.com/article/4758479-stock-market-sleeps-on-stereotaxis-magic-ce-mark?source=feed_tag_editors_picks
Feb 14, 2025 -
0
AngioDynamics Stock Falls Despite CE Mark for Auryon System
https://www.zacks.com/stock/news/2331516/angiodynamics-stock-falls-despite-ce-mark-for-auryon-system?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2331516
Sep 04, 2024 - ANGO's Auryon Atherectomy System earns CE Mark, which expands its European market reach and enhances PAD treatment with advanced laser technology.
0
Femasys Shares Rise on CE Mark & Canada Approval for FemVue MINI
https://www.zacks.com/stock/news/2330875/femasys-shares-rise-on-ce-mark-canada-approval-for-femvue-mini?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2330875
Sep 03, 2024 - FEMY's eco-friendly FemVue MINI receives CE Mark and Health Canada approval, advancing sustainable fallopian tube assessment technology in Europe and Canada.
0
Accuray Stock Rises After Helix System Wins CE Mark for Cancer Care
https://www.zacks.com/stock/news/2328477/accuray-stock-rises-after-helix-system-wins-ce-mark-for-cancer-care?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2328477
Aug 28, 2024 - ARAY's Helix system, now CE Mark approved, aims to close global cancer care gaps with cost-effective, high-throughput radiotherapy for underserved regions.
0
Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval
https://seekingalpha.com/article/4716970-stereotaxis-receives-ce-mark-for-genesisx-nears-magic-approval?source=feed_all_articles
Aug 25, 2024 - Financial writer projects Stereotaxis' new robot GenesisX to drive sales, hitting $69.4 million in 2026 with a price target of $9.3.
0
Eastman (EMN) Gains on Cost Cuts & Innovation Amid Demand Woes
https://www.zacks.com/stock/news/2322639/eastman-emn-gains-on-cost-cuts-innovation-amid-demand-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2322639
Aug 15, 2024 - Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from weak demand in certain markets.
0
Page 1>